Inclusion Criteria:
  -  Newly diagnosed histologically proven locoregional oral squamous cell carcinoma (OSCC) without evidence of distant metastases. OSCC includes the subsites of oral tongue, floor of mouth, gingiva, retromolar trigone and buccal mucosa OR Recurrent or persistent histologically proven locoregional OSCC that was initially treated with surgery alone.
  -  must be eligible for surgical resection
  -  greater than 18 years of age
Exclusion Criteria:
  -  prior immunotherapy or treatment with another anti PD-1 agent besides nivolumab
  -  prior chemotherapy including cetuximab or radiation therapy
  -  concomitant malignancies except cutaneous squamous cell carcinoma or basal cell carcinoma
  -  unresectable primary tumor or regional disease or distant metastases
